Search

everythinglearnresearchcommunity

for

Search:↓

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

Scientists found out the structure of a human enzyme linked to prostate cancer and hair loss, which could help in designing drugs.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

Methylation in specific gene region causes finasteride resistance in some BPH patients.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

Finasteride inhibits enzyme activity in rhesus macaques, suggesting they're useful for evaluating similar drugs.

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

A plant extract was found to effectively block an enzyme related to male hormone-related diseases.

A reliable model for screening type II 5α-reductase inhibitors was created and validated.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

5α-reductase inhibitors help manage symptoms of benign prostatic hyperplasia and may also prevent prostate cancer and treat hair loss.

SRD5A2 enzyme expression varies in benign prostates and can be influenced by inflammation, affecting treatment options.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

5α-reductase inhibitors are effective for treating hair loss in androgenetic alopecia.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

Urtica laetevirens extract significantly reduces 5α-reductase activity.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.